About Upheal
Upheal is a company based in Prague (Czechia) founded in 2021 by Juraj Chrappa and Martin Horvath. Upheal has raised $14.3 million across 3 funding rounds from investors including Calm/Storm, Headline and Credo Ventures. Upheal offers products and services including AI Clinical Notes, Treatment Plans, Session Analytics, and Scheduling. Upheal operates in a competitive market with competitors including Osmind, Valant, Therapy Brands, CentralReach and Credible Behavior Health, among others.
- Headquarter Prague, Czechia
- Founders Juraj Chrappa, Martin Horvath
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Upheal, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.3 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Series A
Nov 14, 2024
-
Investors
Calm/Storm
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Upheal
Upheal offers a comprehensive portfolio of products and services, including AI Clinical Notes, Treatment Plans, Session Analytics, and Scheduling.
AI tool for creating progress notes from therapy sessions
Generates SMART goals for client treatment plans
Provides patterns and insights from therapy sessions
Manages availability and integrates with calendars
People of Upheal
Unlock access to complete
Funding Insights of Upheal
Upheal has successfully raised a total of $14.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Upheal
Upheal has secured backing from 11 investors, including venture fund and angel investors. Prominent investors backing the company include Calm/Storm, Headline and Credo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage tech startups across multiple sectors.
|
Locked | Locked | Locked | |
|
Seed and early-stage investments in technology sectors are targeted.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on pre-seed and series A investments
|
Locked | Locked | Locked |
Investor details for Upheal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Upheal
Investment portfolio details for Upheal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Upheal
Detailed financials for Upheal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Upheal Comparisons
Peer comparison for Upheal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Upheal
Upheal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Osmind, Valant, Therapy Brands, CentralReach and Credible Behavior Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based care platform for mental health
|
|
| Locked | Locked | Locked |
Provider of a SaaS-based EHR and practice management software for mental health providers
|
|
| Locked | Locked | Locked |
Provides EHR and practice management tools for health professionals.
|
|
| Locked | Locked | Locked |
Healthcare software platform for ABA therapies is provided.
|
|
| Locked | Locked | Locked |
Web-based behavioral healthcare EHR and practice management software for healthcare providers
|
|
| Locked | Locked | Locked |
Is a comprehensive Electronic Health Record (EHR) designed for behavioral health and mental health.
|
Detailed competitors of Upheal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Upheal
Complete news archive for Upheal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Upheal
Upheal was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Upheal is headquartered in Prague, Czechia.
Juraj Chrappa is the current CEO of Upheal. They have also founded this company.
Upheal is a funded company, having raised a total of $14.3M across 3 funding rounds to date.
Upheal was founded in 2021 in Prague, Czech Republic, as an AI-based platform focused on electronic health records for mental health professionals. Automated progress notes and analytics are provided to support therapy documentation. Operations center on streamlining administrative tasks and generating insights for clinical decision-making within the health technology sector. The tool is utilized by providers to enhance efficiency in patient care management.
Upheal's top competitors include Osmind, Valant and CentralReach.
Upheal offers AI Clinical Notes, Treatment Plans, Session Analytics, and Scheduling.
Upheal has 11 investors. Key investors include Calm/Storm, Headline, Credo Ventures, Kaya, and Juraj Masar.